Sara Imhof, Ph.D., vice president of the focused initiatives team at the North Carolina Biotechnology Center, has been honored by a regional business publication for her inspiring work to lead North ...

Dayna is a seasoned executive with 20+ years of experience driving growth and talent strategies across multiple industries.

Apriori Bio has become the latest Flagship Pioneering-backed biotech to shed staff, cutting 15 workers to leave 21 still ...

Nick Smith is the President, Founder, and CEO of Sailes, a pioneering company that created market-leading AI software to ...

Inc. (TSVT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start a Phase 2 trial for PRX-115 in 2025.

The once-daily pill combines Opko’s long-acting GLP-1/glucagon dual agonist peptide, dubbed OPK-88006, with Entera’s N-Tab ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

Humanetics Corporation, a clinical-stage pharmaceutical company, has selected Lifecore Biomedical, a fully integrated CDMO, ...

OPKO Health and Entera Bio are partnering to develop a once-daily pill for patients with obesity and other disorders, the companies said on Monday.

Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM)Lifecore ...

Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) have been assigned an average recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat Ratings reports.